Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Operating Margin %: -25.08% (As of Mar. 2026)


BSP:ONCO3 Oncoclinicas Do Brasil Servicos Medicos SA BSP:ONCO3
43 GF Score
Price R$1.38
GF Value R$3.53
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Oncoclinicas Do Brasil Servicos Medicos Operating Margin %?

Oncoclinicas Do Brasil Servicos Medicos BSP:ONCO3 -7.38% 43 Operating Margin % is -25.08% as of Mar. 2026. GuruFocus rates BSP:ONCO3 with a GF Score™ of 43/100 and a GF Value™ of R$3.53 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Oncoclinicas Do Brasil Servicos Medicos ranks worse than 87.43% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Oncoclinicas Do Brasil Servicos Medicos's Operating Income for the three months ended in Mar. 2026 was R$-291 Mil. Oncoclinicas Do Brasil Servicos Medicos's Revenue for the three months ended in Mar. 2026 was R$1,161 Mil. Therefore, Oncoclinicas Do Brasil Servicos Medicos's Operating Margin % for the quarter that ended in Mar. 2026 was -25.08%.

The historical rank and industry rank for Oncoclinicas Do Brasil Servicos Medicos's Operating Margin % or its related term are showing as below:

BSP:ONCO3' s Operating Margin % Range Over the Past 10 Years
Min: -51.58   Med: 6.56   Max: 13.48
Current: -51.58


BSP:ONCO3's Operating Margin % is ranked worse than
87.43% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 4.845 vs BSP:ONCO3: -51.58

Oncoclinicas Do Brasil Servicos Medicos's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Oncoclinicas Do Brasil Servicos Medicos's Operating Income for the three months ended in Mar. 2026 was R$-291 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was R$-2,789 Mil.


Oncoclinicas Do Brasil Servicos Medicos  (BSP:ONCO3) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Oncoclinicas Do Brasil Servicos Medicos Operating Margin % Related Terms


Oncoclinicas Do Brasil Servicos Medicos Operating Margin % Historical Data

* Premium members only.

The historical data trend for Oncoclinicas Do Brasil Servicos Medicos's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncoclinicas Do Brasil Servicos Medicos Operating Margin % Chart

Oncoclinicas Do Brasil Servicos Medicos Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial 6.44 10.91 13.48 -2.29 -42.98

Oncoclinicas Do Brasil Servicos Medicos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.09 3.42 -117.67 -64.66 -25.08

BSP:ONCO3 vs HCA, THC, DVA: Operating Margin % Comparison

For the Medical Care Facilities subindustry, Oncoclinicas Do Brasil Servicos Medicos's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncoclinicas Do Brasil Servicos Medicos Operating Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oncoclinicas Do Brasil Servicos Medicos's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Oncoclinicas Do Brasil Servicos Medicos's Operating Margin % falls into.


BSP:ONCO3
43GF Score
Oncoclinicas Do Brasil Servicos Medicos SA BSP:ONCO3
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncoclinicas Do Brasil Servicos Medicos Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Oncoclinicas Do Brasil Servicos Medicos's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-2466.519 / 5739.367
=-42.98 %

Oncoclinicas Do Brasil Servicos Medicos's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-291.165 / 1160.771
=-25.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -25.08% mean?
Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) has a Operating Margin % of -25.08% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Oncoclinicas Do Brasil Servicos Medicos and its competitors. According to the industry distribution chart, Oncoclinicas Do Brasil Servicos Medicos ranks #584 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 87.4%.
Is Oncoclinicas Do Brasil Servicos Medicos' Operating Margin % too high?
Oncoclinicas Do Brasil Servicos Medicos' current Operating Margin % is -25.08%. Based on the distribution chart, Oncoclinicas Do Brasil Servicos Medicos ranks #584 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Oncoclinicas Do Brasil Servicos Medicos has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oncoclinicas Do Brasil Servicos Medicos' Operating Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Oncoclinicas Do Brasil Servicos Medicos ranks #584 out of 668 companies for Operating Margin %. This places Oncoclinicas Do Brasil Servicos Medicos in the lower half of its industry. The industry median Operating Margin % is 4.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Oncoclinicas Do Brasil Servicos Medicos and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oncoclinicas Do Brasil Servicos Medicos's current Operating Margin % is -25.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncoclinicas Do Brasil Servicos Medicos stock overvalued right now?
Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) is currently considered Possible Value Trap. The stock's GF Value™ is R$3.53, compared to a current price of R$1.38 — trading 60.9% below its estimated fair value. The current Operating Margin % is -25.08%. Oncoclinicas Do Brasil Servicos Medicos' overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3), the current Operating Margin % is -25.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Overvalued in 2026?

Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos stock appears to be undervalued. The current stock price of R$1.38 is trading 60.9% below its estimated GF Value™ of R$3.53. GuruFocus considers Oncoclinicas Do Brasil Servicos Medicos to be Possible Value Trap.

Key valuation signals for BSP:ONCO3:

  • Operating Margin %: -25.08%
  • GF Value™: R$3.53 vs. price of R$1.38 (60.9% below fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the BSP:ONCO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oncoclinicas Do Brasil Servicos Medicos Business Description

Address Avenida Presidente Juscelino Kubitschek, No. 510, 2nd Floor, Vila Nova Conceicao, Sao Paulo, SP, BRA, 04543-906
Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology, and bone marrow transplantation, complementary care. The Group operates solely in the healthcare services segment, with an emphasis on oncology.
43GF Score

Get the complete analysis for BSP:ONCO3

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$1.38
Price
R$3.53
GF Value